![]() Semi-Good News for Pharm? The Vioxx debacle might finally be over and with some possible positive side-effects. Merck has agreed to pay $4.85 billion to plaintiffs. Merck won most of the trials that did make it to juries, which should encourage pharm execs with fingers on the development trigger. And, though the $4.85 billion almost...
IN THE CURRENT ISSUE OF MIN'S B2B
SEARCH PREVIOUS ISSUES
MOST READ
COMMENTS
|
App Central min's App Central (for min subscribers only): Stay on top of mobile app developments with exclusive app reviews, analysis and data.
Please enter the following information to have a link to The Skinny emailed to your iPhone:
White Papers
min Contests
EventsBest of the Web, April 3, 2012 min's Sales Executive of the Year Awards min Press
Events Calendar
min's Best of the Web Awards |
| Copyright © 2012 Access Intelligence, LLC. All rights reserved. Reproduction in whole or in part in any form or medium without express written permission of Access Intelligence, LLC is prohibited. For more details please see Terms and Conditions. |